Harnik, Michael Alexander http://orcid.org/0000-0002-0191-5742
Kesselring, Pascal
Ott, Alexander
Urman, Richard D.
Luedi, Markus M.
Funding for this research was provided by:
University of Bern
Article History
Accepted: 7 May 2023
First Online: 6 July 2023
Compliance with Ethical Standards
:
: Not applicable
: Not applicable
: Not applicable
: Michael A. Harnik, Pascal Kesselring, Alexander Ott, and Markus M. Luedi declare no conflict of interest. Richard D. Urman reports fees/funding from AcelRx, Medtronic, Pfizer and Merck. No funding was involved.
: This article does not contain any studies with human or animal subjects performed by any of the authors.